Huge budget shortfalls are prompting a handful of states including Washington, Texas and South Carolina to begin discussing a once-unthinkable scenario: dropping out of the Medicaid insurance program for the poor, reports the Wall Street Journal.
Xanodyne Pharmaceuticals Inc., developer and maker of drugs for women's health care and pain management, has completed a $50 million round of equity financing. The Kentucky drug maker will use the money for development and commercialization efforts, CEO Michael Valentino said.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.